Whether redundant functions in the AP1 family, cooperating tissues specific transcription factors, alternative genetic trajectories, re-wired oncogenic signaling, or non-cell-autonomous processes explain the compensation of FRA1 for tumor formation is unclear and demands additional investigations. This evidence concerns the gene FOSL1 and neoplasm.